First, we examined the AKAP9 I2558 M mutation in differentiated SH‐SY5Y cells, but future studies utilizing AD patient‐derived human‐induced pluripotent stem cells could provide a better in vitro model to understand AKAP9 functions at different stages of disease progression. This evidence concerns the gene AKAP9 and Alzheimer disease.